{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:42:37Z","timestamp":1761619357347,"version":"3.44.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ophtha.2009.08.028","type":"journal-article","created":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T04:08:09Z","timestamp":1262232489000},"page":"517-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of Coagulation-Balance Gene Predictors on Efficacy of Photodynamic Therapy for Choroidal Neovascularization in Pathologic Myopia"],"prefix":"10.1016","volume":"117","author":[{"given":"Francesco","family":"Parmeggiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato","family":"Gemmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Semeraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Incorvaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2009.08.028_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.survophthal.2007.12.004","article-title":"Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment","volume":"53","author":"Soubrane","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ajo.2006.05.061","article-title":"Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases","volume":"142","author":"Kaiser","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib3","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.ophtha.2007.03.043","article-title":"Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study","volume":"114","author":"Chan","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.08.028_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bjo.2006.101337","article-title":"Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues","volume":"91","author":"Rosenfeld","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0161-6420(01)00544-9","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial\u2014VIP report no. 1","volume":"108","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.08.028_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0161-6420(02)01998-X","article-title":"Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial\u2013-VIP report no. 3","volume":"110","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.08.028_bib7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bjo.2004.041624","article-title":"Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up","volume":"88","author":"Lam","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ajo.2005.03.050","article-title":"Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy","volume":"140","author":"Krebs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib9","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/bjo.2005.074716","article-title":"Choroidal neovascularisation in pathological myopia: an update in management","volume":"89","author":"Chan","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.iae.0000244260.52901.2e","article-title":"Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia: results from a randomized pilot study","volume":"26","author":"Costa","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2009.08.028_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/IAE.0b013e31804b1e6f","article-title":"Photodynamic therapy for Taiwanese patients with pathologic myopia: a 2-year follow-up","volume":"27","author":"Chen","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2009.08.028_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ajo.2007.10.032","article-title":"Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls","volume":"145","author":"Hayashi","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(00)00158-2","article-title":"Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration","volume":"45","author":"Schmidt-Erfurth","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","article-title":"Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes","volume":"240","author":"Schlotzer-Schrehardt","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib15","first-page":"830","article-title":"Photodynamic effects on choroidal neovascularization and physiological choroid","volume":"43","author":"Schmidt-Erfurth","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2009.08.028_bib16","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1167\/iovs.02-0604","article-title":"Sequence of early vascular events after photodynamic therapy","volume":"44","author":"Michels","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2009.08.028_bib17","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.ophtha.2005.09.007","article-title":"Time course and morphology of vascular effects associated with photodynamic therapy","volume":"112","author":"Schmidt-Erfurth","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.08.028_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajo.2004.04.055","article-title":"Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia","volume":"138","author":"Ergun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajo.2004.05.074","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment","volume":"138","author":"Axer-Siegel","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10384-005-0259-z","article-title":"Photodynamic therapy in macular diseases of Asian populations: when East meets West","volume":"50","author":"Chan","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.eye.6701991","article-title":"Review of first year result of photodynamic therapy on age-related macular degeneration in Chinese population","volume":"20","author":"Yang","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2009.08.028_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000076692","article-title":"Modulation of thrombophilia genes by environmental factors","volume":"32","author":"Bernardi","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.ophtha.2009.08.028_bib23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood.V100.3.743","article-title":"Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms","volume":"100","author":"Ari\u00ebns","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ophtha.2009.08.028_bib24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.bbapap.2006.06.007","article-title":"The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma","volume":"1764","author":"Shemirani","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ophtha.2009.08.028_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2000-8469","article-title":"Homocysteine, coagulation, platelet function, and thrombosis","volume":"26","author":"Coppola","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ophtha.2009.08.028_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00129785-200101030-00004","article-title":"Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences","volume":"1","author":"Schwahn","year":"2001","journal-title":"Am J Pharmacogenomics"},{"key":"10.1016\/j.ophtha.2009.08.028_bib27","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1001\/jama.288.16.2023","article-title":"MTHFR 677C\u2013>T polymorphism and risk of coronary heart disease: a meta-analysis","volume":"288","author":"Klerk","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2009.08.028_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000083824","article-title":"Gene-gene and gene-environment interactions in mild hyperhomocysteinemia","volume":"33","author":"D'Angelo","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.ophtha.2009.08.028_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10545-006-0106-5","article-title":"Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview","volume":"29","author":"Castro","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ophtha.2009.08.028_bib30","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1515\/CCLM.2007.324","article-title":"Defects in homocysteine metabolism: diversity among hyperhomocyst(e)inemias","volume":"45","author":"Matthews","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ophtha.2009.08.028_bib31","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/FPC.0b013e3282f12a4e","article-title":"Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration","volume":"17","author":"Parmeggiani","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.ophtha.2009.08.028_bib32","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1167\/iovs.07-1654","article-title":"Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration","volume":"49","author":"Parmeggiani","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2009.08.028_bib33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/IAE.0b013e31816079c3","article-title":"Effect of aspirin therapy on photodynamic therapy with verteporfin for choroidal neovascularization","volume":"28","author":"Ranchod","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2009.08.028_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajh.1104","article-title":"A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases","volume":"67","author":"Gemmati","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1055-9965.787.13.5","article-title":"Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults","volume":"13","author":"Gemmati","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ophtha.2009.08.028_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-0037-1614074","article-title":"Ethnic heterogeneity of the factor XIII Val34Leu polymorphism","volume":"84","author":"Atti\u00e9-Castro","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ophtha.2009.08.028_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/jmg.40.8.619","article-title":"Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide","volume":"40","author":"Wilcken","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.ophtha.2009.08.028_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9394(03)00223-X","article-title":"Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report 1","volume":"136","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/bjo.2007.132795","article-title":"Photodynamic therapy to treat choroidal neovascularisation in highly myopic patients: 4 years' outcome","volume":"92","author":"Ruiz-Moreno","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1177\/112067210801800616","article-title":"Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review","volume":"18","author":"Costagliola","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/14622416.10.1.81","article-title":"Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration","volume":"10","author":"Parmeggiani","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ophtha.2009.08.028_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ophtha.2005.10.015","article-title":"Vision loss after PDT","volume":"113","author":"Parmeggiani","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.08.028_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/09537100400020187","article-title":"Homocysteinemia is inversely correlated with platelet count and directly correlated with sE- and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase","volume":"16","author":"Rongioletti","year":"2005","journal-title":"Platelets"},{"issue":"suppl","key":"10.1016\/j.ophtha.2009.08.028_bib44","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.cdd.4401451","article-title":"Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease","volume":"11","author":"Austin","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ophtha.2009.08.028_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1389200052997357","article-title":"Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function","volume":"6","author":"Weiss","year":"2005","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.ophtha.2009.08.028_bib46","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.100.11.1161","article-title":"Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans","volume":"100","author":"Kanani","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ophtha.2009.08.028_bib47","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1093\/jn\/133.11.3588","article-title":"Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells","volume":"133","author":"Holven","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.ophtha.2009.08.028_bib48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1254\/jphs.91.182","article-title":"Stress and vascular responses: endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationships with oxidative stress","volume":"91","author":"Sakurai","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.ophtha.2009.08.028_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1538-7836.2006.02275.x","article-title":"Enhanced platelet activation in hyperhomocysteinemic individuals","volume":"5","author":"Holven","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ophtha.2009.08.028_bib50","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.ATV.0000201039.21705.dc","article-title":"Stereospecific and redox-sensitive increase in monocyte adhesion to endothelial cells by homocysteine","volume":"26","author":"Postea","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1562\/0031-8655(2002)075<0036:IOOSIN>2.0.CO;2","article-title":"Involvement of oxidative stress in NF-kappaB activation in endothelial cells treated by photodynamic therapy","volume":"75","author":"Volanti","year":"2002","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00417-004-0870-6","article-title":"Histological findings of a surgically excised myopic choroidal neovascular membrane after photodynamic therapy: a case report","volume":"242","author":"Scupola","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3341\/kjo.2006.20.1.18","article-title":"Indocyanine green angiographic features of myopic subfoveal choroidal neovascularization as a prognostic factor after photodynamic therapy","volume":"20","author":"Byeon","year":"2006","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib54","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1046\/j.1538-7836.2003.00339.x","article-title":"No Val34Leu polymorphism of the gene for factor XIIIA subunit was detected by ARMS-RACE method in three Asian populations","volume":"1","author":"Okumura","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ophtha.2009.08.028_bib55","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/01.ATV.0000081636.25235.C6","article-title":"Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression","volume":"23","author":"Dardik","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ophtha.2009.08.028_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1538-7836.2005.01473.x","article-title":"Factor XIII (FXIII) and angiogenesis","volume":"4","author":"Dardik","year":"2006","journal-title":"J Thromb Haemost"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009009294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009009294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:00:51Z","timestamp":1758981651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642009009294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0161642009009294"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.08.028","relation":{},"ISSN":["0161-6420"],"issn-type":[{"type":"print","value":"0161-6420"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Coagulation-Balance Gene Predictors on Efficacy of Photodynamic Therapy for Choroidal Neovascularization in Pathologic Myopia","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}